Biological/Vaccine: hBRCA84D CAR T cells clinical trials

Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma

This study looks at a new cell therapy called CAR T cells for children, teenagers, and young adults (ages 1-24) with specific types of sarcoma (a type of cancer) that have come back or not responded to previous treatments.